Polycystic Ovaries and Recurrent Miscarriage--a Reappraisal
Overview
Authors
Affiliations
The prevalence of polycystic ovaries (PCO) was established amongst 2199 consecutive women (median age 33 years; range 19-46) with a history of recurrent miscarriage (median 3; 3-14). A diagnosis of PCO was made if the ovarian volume was enlarged (>9 ml), there were >/=10 cysts of 2-8 mm in diameter in one plane and there was increased density of the stroma. In a cohort study, the prospective pregnancy outcome of 486 of the women scanned who were antiphospholipid antibody negative and who received no pharmacological treatment during their next pregnancy was studied. The prevalence of PCO was 40.7% (895/2199). The livebirth rate was similar amongst women with PCO (60.9%; 142/233) compared to that amongst women with normal ovarian morphology (58.5%; 148/253; not significant). Neither an elevated serum luteinizing hormone concentration (>10 IU/l) nor an elevated serum testosterone concentration (>3 nmol/l) was associated with an increased miscarriage rate. Polycystic ovarian morphology is not predictive of pregnancy loss amongst ovulatory women with recurrent miscarriage conceiving spontaneously. The search for a specific endocrine abnormality that can divide women with PCO into those with a good and those with a poorer prognosis for a future successful pregnancy continues.
The Value of Parental Karyotyping in Recurrent Pregnancy Loss Lies in Individual Risk Assessments.
Popescu-Hobeanu G, Serban Sosoi S, Cucu M, Streata I, Dobrescu A, Plesea R Medicina (Kaunas). 2024; 60(11).
PMID: 39596963 PMC: 11596323. DOI: 10.3390/medicina60111778.
He J, Liu A, Shen H, Jiang Y, Gao M, Yu L Front Endocrinol (Lausanne). 2024; 15:1335106.
PMID: 39398336 PMC: 11466764. DOI: 10.3389/fendo.2024.1335106.
Polycystic ovary syndrome and recurrent pregnancy loss, a review of literature.
Wartena R, Matjila M Front Endocrinol (Lausanne). 2023; 14:1183060.
PMID: 38027110 PMC: 10643146. DOI: 10.3389/fendo.2023.1183060.
Zhang L, Du Y, Zhou J, Li J, Shen H, Liu Y Front Endocrinol (Lausanne). 2023; 14:1215469.
PMID: 37795359 PMC: 10545878. DOI: 10.3389/fendo.2023.1215469.
Di Lorenzo M, Cacciapuoti N, Lonardo M, Nasti G, Gautiero C, Belfiore A Curr Nutr Rep. 2023; 12(3):527-544.
PMID: 37213054 PMC: 10444658. DOI: 10.1007/s13668-023-00479-8.